Clinical Trials Logo

Clinical Trial Summary

The purpose of this prospective randomized controlled trial is to determine whether using the Oxygen Reserve Index can prevent hyperoxemia in pediatric patients receiving single-lung ventilation. Participants will have their FiO2 adjusted in a prescribed manner based on the arm to which they are assigned. The researchers will compare whether blood oxygen levels were lower in the ORI group.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05912543
Study type Interventional
Source Seoul National University Hospital
Contact Ji-Hyun Lee, M.D., Ph.D.
Phone 02-2072-3664
Email muslab6@snu.ac.kr
Status Recruiting
Phase N/A
Start date July 25, 2022
Completion date May 31, 2025

See also
  Status Clinical Trial Phase
Completed NCT04211246 - Oxygen Reserve Index to Reduce Hyperoxia N/A
Recruiting NCT04772183 - OxyGap : Comparison Between Different Pulse Oximeter and With the Arterial Blood Gase
Not yet recruiting NCT06102499 - Comparison of Pulse Oximetry (SpO2) With Different Oximeters and Arterial Saturation (SaO2): Oxygap2 Study
Recruiting NCT04198077 - Conservative Versus Conventional Oxygen Administration in Critically Ill Patients Phase 4
Completed NCT05505032 - Oxygen Reserve Index and Prevention of Hyperoxemia Phase 4
Completed NCT04965844 - Closed-loop Oxygen Control for High Flow Nasal Therapy N/A